Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) EBT (2016 - 2025)

Nephros (NEPH) has 16 years of EBT data on record, last reported at $340000.0 in Q3 2025.

  • For Q3 2025, EBT rose 85.79% year-over-year to $340000.0; the TTM value through Sep 2025 reached $1.5 million, up 267.84%, while the annual FY2024 figure was $89000.0, 105.65% up from the prior year.
  • EBT reached $340000.0 in Q3 2025 per NEPH's latest filing, up from $246000.0 in the prior quarter.
  • Across five years, EBT topped out at $579000.0 in Q1 2025 and bottomed at -$1.6 million in Q1 2022.
  • Average EBT over 5 years is -$477421.1, with a median of -$422000.0 recorded in 2023.
  • Peak YoY movement for EBT: crashed 50.97% in 2022, then surged 428.98% in 2025.
  • A 5-year view of EBT shows it stood at -$726000.0 in 2021, then rose by 5.1% to -$689000.0 in 2022, then grew by 9.72% to -$622000.0 in 2023, then surged by 158.52% to $364000.0 in 2024, then dropped by 6.59% to $340000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $340000.0 in Q3 2025, $246000.0 in Q2 2025, and $579000.0 in Q1 2025.